Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: New Dutton report

Jun 17, 2007 07:48PM
I don't take the dutton reports too seriously.  Their price target is $0.75 in 12 months. Obviously they are not aware that invalidating patents is next to  impossible. With that known, PTSC's patents must stand. We might see $0.75 by the end of this week.

Jun 17, 2007 09:24PM

Jun 18, 2007 03:04AM

Jun 18, 2007 03:26AM

Jun 18, 2007 03:29AM

Jun 18, 2007 04:36AM
Share
New Message
Please login to post a reply